CYCS and cervical cancer: Moreover, LIQ’s close analog, isoliquiritigenin, has been reported to trigger caspase-8 in Ca Ski cervical cancer cells, followed by cytochrome c release, activation of the caspase cascade, and PARP cleavage [74].